RxSight (RXST) Total Liabilities (2020 - 2026)

RxSight's Total Liabilities history runs 7 years deep, the most recent figure standing at $36.7 million for Q1 2026.

• Quarterly Total Liabilities rose 8.81% year-over-year to $36.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.7 million (up 8.81% YoY) and the FY2025 annual result came in at $36.1 million, down 3.2% from the prior year.
• Total Liabilities was $36.7 million for Q1 2026 at RxSight, up from $36.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $60.3 million in Q4 2022 and bottomed at $19.2 million in Q1 2024.
• A 5-year average of $38.8 million and a median of $36.1 million in 2025 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2024 — Total Liabilities sank 66.56% — and 2025, when it surged 75.34%.
• RxSight's Total Liabilities stood at $60.3 million in 2022, then plunged by 63.18% to $22.2 million in 2023, then soared by 68.22% to $37.3 million in 2024, then decreased by 3.2% to $36.1 million in 2025, then climbed by 1.57% to $36.7 million in 2026.
• Business Quant data shows RXST's Total Liabilities at $36.7 million in Q1 2026, $36.1 million in Q4 2025, and $32.6 million in Q3 2025.